PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
TI  - Comparison of Tedizolid Phosphate versus Linezolid in a Phase 3 Study in Patients with ABSSSI
DP  - 2012 Dec 01
TA  - MD Conference Express
PG  - 28--29
VI  - 12
IP  - 14
4099  - http://mdc.sagepub.com/content/12/14/28.2.short
4100  - http://mdc.sagepub.com/content/12/14/28.2.full
AB  - In a Phase 3 study comparing tedizolid, a second generation oxazolidinone, to linezolid in patients with acute bacterial skin and skin structure infections (ABSSSI), tedizolid phosphate was noninferior and demonstrated high microbiological efficacy compared with linezolid. This article presents a poster [De Anda et al. ICAAC 2012 L1–1665] on the outcomes using the the new Food and Drug Administration method for assessing clinical response, programmatic assessment, and the traditional post-treatment investigator assessment.